ISTA Pharmaceuticals' P2P Acquisition

ISTA Pharmaceuticals raised a round of funding on March 27, 2012. Investors include Bausch & Lomb.

ISTA Pharmaceuticals develops ophthalmic pharmaceuticals. In March 2012, ISTA Pharmaceuticals was acquired by Bausch & Lomb. The valuation of ISTA Pharmaceuticals was $500 million.…

Articles about ISTA Pharmaceuticals' P2P Acquisition: